Events

Dr. Lila Hope of Cooley LLP discussed a biotech company’s timeline in relation to product development and summarised the different third party agreements a company might contract along the length of this timeline. These agreements could range from research collaborations, sponsored research agreements, technology licenses, engagement of service providers, MTAs to corporate partnerships.

Financing for the life sciences and healthcare industry is poised to remain robust in the years ahead. Where will the money flow? In this panel discussion, we bring together leading experts from venture capital, private equity and healthcare consulting. Join us for a lively discussion on which areas of innovation are attracting the most funding and what’s coming next.

The global Med Tech market is projected to grow at a rate of 4.4% annually, making it one of the fastest developing industry sectors. The stage is set for Singapore to grow into a vibrant, global Med Tech hub with an industry-ready workforce, “plug and play” infrastructure, and the growth of public-private partnerships, along with considerable government support.

Save the date! ITAP will be held digitally from 20 to 22 October 2020.

Biotech Connection Singapore (BCS) partners with Singapore Week of Innovation and TeCHnology (SWITCH), the leading tech festival for the Global-Asia innovation ecosystem. Together with the Singapore FinTech Festival, SFF x SWITCH will take place on 7-11 December 2020—get ready for an exciting week-long, round-the-clock, digital and physical event! You can […]

In this webinar, we will feature the story of PairX Bio (“PairX”), a new Singapore-based Biotech Company in cancer immunotherapy and latest spin-off from Duke-NUS AMC. The panel featuring Dr Raymond Lee, Scientific Co-founder of PairX; Mr XQ Lin, an investor in PairX; and Ms Cheryl McCaffrey, Director of Duke-NUS’ CTed, will share their insights on the opportunities and challenges of starting a biotech company.